Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans
Background. The chemokine CXCL10 is specifically upregulated during experimental development of plaque with an unstable phenotype. In this study we evaluated the functional consequences of these findings in mice and humans. Methods and Results. In ApoE-/- mice, we induced unstable plaque with using...
Saved in:
Main Authors: | Dolf Segers (Author), Jonathan A. Lipton (Author), Pieter J. M. Leenen (Author), Caroline Cheng (Author), Dennie Tempel (Author), Gerard Pasterkamp (Author), Frans L. Moll (Author), Rini de Crom (Author), Rob Krams (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship of MMP-14 and TIMP-3 Expression with Macrophage Activation and Human Atherosclerotic Plaque Vulnerability
by: Jason L. Johnson, et al.
Published: (2014) -
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.
by: Luciana Gabriel Nogueira, et al.
Published: (2012) -
Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms
by: Grant O. Holdren, et al.
Published: (2014) -
Chemokine CXCL1 is responsible for cocaine‐induced reward in mice
by: Fumihiro Saika, et al.
Published: (2018) -
Characterization and Antimicrobial Activity of the Teleost Chemokine CXCL20b
by: Xun Xiao, et al.
Published: (2020)